You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tositumomab

Showing 1 - 25 of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Ann Arbor (Iodine I 131 Tositumomab)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Iodine I 131 Tositumomab
  • Ann Arbor, Michigan
    University of Michigan
Mar 16, 2022

Follicular Lymphoma Trial in Chicago (Bortezomib and Tositumomab I-131)

Terminated
Has Results
  • Follicular Lymphoma
  • Bortezomib and Tositumomab I-131
  • Chicago, Illinois
    Rush University Medical Center
Oct 6, 2021

Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

Active, not recruiting
  • Mantle Cell Lymphoma
  • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
  • Basking Ridge, New Jersey
  • +4 more
Dec 1, 2022

Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation

Completed
Has Results
  • Lymphoma, B-Cell
  • +2 more
  • Autologous transplantation using rituxan/BEAM
  • Autologous transplantation using Bexxar/BEAM
  • New Haven, Connecticut
  • +35 more
Oct 21, 2021

Lymphoma, Mantle-Cell Trial (Tositumomab and Iodine I 131 Tositumomab followed by CHOP)

Completed
Has Results
  • Lymphoma, Mantle-Cell
  • Tositumomab and Iodine I 131 Tositumomab followed by CHOP
  • (no location specified)
Nov 19, 2019

Lymphoma Trial in United States (biological, drug, radiation)

Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
Sep 23, 2022

Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)

Completed
Has Results
  • Lymphoma, Follicular
  • Scarborough, Maine
  • +3 more
Apr 27, 2021

Lymphoma Trial in United States (biological, drug, radiation)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +5 more
  • Mobile, Alabama
  • +113 more
Aug 15, 2019

Hodgkin's Disease Trial in Baltimore (I-131 Tositumomab therapeutic regimen)

Completed
Has Results
  • Hodgkin's Disease
  • I-131 Tositumomab therapeutic regimen
  • Baltimore, Maryland
    Johns Hopkins Medical Institutions
Jul 31, 2018

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in

Completed
Has Results
  • Lymphoma
  • Patient-specific dosimetry
  • conventional dosimetry
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 27, 2018

Non-Hodgkin's Lymphoma Trial in Ann Arbor, New York (bortezomib, tositumomab)

Completed
  • Non-Hodgkin's Lymphoma
  • bortezomib, tositumomab
  • Ann Arbor, Michigan
  • +1 more
Aug 9, 2018

Lymphoid Leukemia in Remission, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in Seattle

Completed
Has Results
  • Lymphoid Leukemia in Remission
  • +6 more
  • Tositumomab and Iodine I 131 Tositumomab
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Oct 10, 2017

Lymphoma Trial in Omaha (tositumomab and iodine I 131 tositumomab)

Terminated
  • Lymphoma
  • tositumomab and iodine I 131 tositumomab
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jan 13, 2018

Lymphoma, Non-Hodgkin Trial (Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas (Tositumomab and

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas (Tositumomab and Iodine I 131 Tositumomab)
  • (no location specified)
Aug 1, 2017

Lymphoma, Follicular Trial (Follicular Lymphoma)

Completed
Has Results
  • Lymphoma, Follicular
  • Follicular Lymphoma
  • (no location specified)
Jun 9, 2017

Anaplastic Large Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Seattle (drug, radiation, procedure)

Completed
Has Results
  • Anaplastic Large Cell Lymphoma
  • +16 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jul 21, 2017

Lymphoma, Non-Hodgkin Trial in Stanford (Bexxar (tositumomab), External beam radiotherapy (XRT), Potassium Iodide (KI))

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Bexxar (tositumomab)
  • +2 more
  • Stanford, California
    Stanford University School of Medicine
Feb 9, 2017

Lymphoma Trial in Stanford (Bexxar, Acetaminophen, Diphenhydramine)

Completed
Has Results
  • Lymphoma
  • Stanford, California
    Stanford University School of Medicine
Feb 28, 2017

Lymphoma, Non-Hodgkin Trial (Tositumomab and Iodine I 131 Tositumomab)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Tositumomab and Iodine I 131 Tositumomab
  • (no location specified)
Nov 30, 2016

Lymphoma, Non-Hodgkin Trial in Walla Walla, Pierre-Benite Cedex, Manchester (Tositumomab and Iodine I 131 Tositumomab,

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Tositumomab and Iodine I 131 Tositumomab
  • Rituximab
  • Walla Walla, Washington
  • +2 more
Nov 18, 2016

Follicular Lymphoma Trial in Ann Arbor (Bexxar, Low Dose Methotrexate)

Terminated
Has Results
  • Follicular Lymphoma
  • Ann Arbor, Michigan
    University of Michigan
Dec 1, 2016

Lymphoma, Non-Hodgkin Trial (Tositumomab and Iodine I 131 Tositumomab (Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody))

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Tositumomab and Iodine I 131 Tositumomab (Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody)
  • (no location specified)
Nov 23, 2016

Lymphoma, Non-Hodgkin Trial (Iodine I 131 Tositumomab Therapeutic Regimen)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Iodine I 131 Tositumomab Therapeutic Regimen
  • (no location specified)
Nov 18, 2016

Lymphoma, B-Cell Trial in Durham (cyclophosphamide, etoposide, rituximab)

Completed
Has Results
  • Lymphoma, B-Cell
  • Durham, North Carolina
    Duke University Medical Center
Apr 19, 2017

Lymphoma, Non-Hodgkin Trial (cycolophosphamide, vacristine, and pednisone (CVP) x6 cycles followed by tositumomab and iodine I

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • cycolophosphamide, vacristine, and pednisone (CVP) x6 cycles followed by tositumomab and iodine I 131 tositumomab.
  • (no location specified)
Nov 21, 2016